Nanobiotix (NBTX) Institutional Ownership → Invest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a Century (From Starpax) (Ad) Free NBTX Stock Alerts $7.31 +0.46 (+6.72%) (As of 12:52 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Nanobiotix (NASDAQ:NBTX)CurrentInstitutional OwnershipPercentage38.81%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$19.88MNumber ofInstitutional Sellers(last 12 months)0 Get NBTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Nanobiotix stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NBTX Institutional Buying and Selling by Quarter Ad StarpaxInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpax’s technology is set to revolutionize cancer care and improve the lives of patients worldwide. Be part of a mission to create a world where cancer treatment is more effective, safe and accessible.Invest today Nanobiotix Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails1/26/2024 Baillie Gifford & Co.2,869,030$20.89M0.0%+48.2%6.087% 11/13/2023 Baillie Gifford & Co.1,936,195$16.94M0.0%+38.3%5.350% 11/9/2023 Johnson & Johnson959,637$8.40M3.1%N/A2.652% 8/17/2021Woodline Partners LP59,994$827K0.0%-7.0%0.174% 5/18/2021Millennium Management LLC22,082$332K0.0%-53.3%0.066% 5/17/2021Perceptive Advisors LLC1,059,800$15.94M0.2%-3.7%3.043% 5/17/2021Woodline Partners LP64,514$970K0.0%-7.8%0.194% 5/12/2021 UBS Group AG70,182$1.06M0.0%+20,183.8%0.211% 2/16/2021Orbimed Advisors LLC500,000$8.25M0.1%N/A1.500% 2/11/2021 Artal Group S.A.1,000,000$16.50M0.4%N/A2.999% 2/11/2021Monashee Investment Management LLC15,000$248K0.0%N/A0.045% 2/11/2021Tybourne Capital Management HK Ltd.750,000$12.38M0.3%N/A2.250% 2/10/2021 Baillie Gifford & Co.1,400,000$23.10M0.0%N/A4.199% (Data available from 1/1/2016 forward) NBTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NBTX shares? During the previous two years, the following institutional investors and hedge funds held shares of Nanobiotix shares: Baillie Gifford & Co. ($20.89M), Johnson & Johnson ($8.40M).Learn more on NBTX's institutional investors. What percentage of Nanobiotix stock is owned by institutional investors? 38.81% of Nanobiotix stock is owned by institutional investors. Learn more on NBTX's institutional investor holdings. Which institutional investors have been buying Nanobiotix stock? The following institutional investors have purchased Nanobiotix stock in the last 24 months: Baillie Gifford & Co. ($1.47M), and Johnson & Johnson ($959.64K). How much institutional buying is happening at Nanobiotix? Institutional investors have bought a total of 2,428,667 shares in the last 24 months. This purchase volume represents approximately $19.88M in transactions. Related Companies: ESSA Pharma Institutional Ownership Aquestive Therapeutics Institutional Ownership Procaps Group Institutional Ownership Akebia Therapeutics Institutional Ownership Verastem Institutional Ownership UroGen Pharma Institutional Ownership XOMA Institutional Ownership Vanda Pharmaceuticals Institutional Ownership Neoleukin Therapeutics Institutional Ownership Inozyme Pharma Institutional Ownership This page (NASDAQ:NBTX) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxHUGE BUY ALERT: Move Fast, Musk...Stansberry ResearchDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nanobiotix S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.